Company Performance Metrics
- Casey Halpern: Founder & Chairman
- Emily Mirro: President & Co-Founder
Synchneuro develops noninvasive neuromodulation technology that uses EEG-informed timing to synchronize magnetic stimulation with brain rhythms. The portfolio includes a platform that combines transcranial magnetic stimulation hardware with software for signal acquisition, analysis, and individualized treatment planning. Applications focus on
neuropsychiatric and neurological symptoms such as depression, post-traumatic stress, and cognitive impairment, pending clinical evidence and regulatory authorization. Offerings also cover clinician training, protocol development, and tools that document sessions and outcomes in research or outpatient settings. Data services provide dashboards and analytics to support protocol refinement and multicenter studies. Product availability, indications, and claims depend on jurisdiction and ongoing trials.